Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Chugai Venture Fund (CVF) is a venture capital firm based in North America, focusing on the life sciences sector. As a subsidiary of Chugai Pharmaceutical Co., Ltd., CVF supports the development of novel medicines and innovative technologies. The firm primarily invests in early-stage companies, emphasizing biotech and healthcare.
Chugai Venture Fund invests in pre-seed to seed+ stage life science enterprises. The firm provides funding and resources to management teams developing innovative therapies aimed at improving patient care. Their investment strategy centers on fostering innovation within the healthcare sector.
Notable portfolio activities include Ten63 Therapeutics, which has secured strategic financing to advance artificial intelligence in drug discovery, and Repertoire® Immune Medicines, which announced a collaboration with Lilly to develop therapies for autoimmune diseases.
Email your pitch deck to cvfinfo@chugaiventurefund.com for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.